ESR1 and breast cancer: These ERα−polyubiquitination inhibitor proteins (EPIPs)—including kinases, transcriptional co-regulators, E3 ubiquitin ligases, and deubiquitinases—are often overexpressed in BC tissues, contributing to sustained ERα signaling and tamoxifen resistance.